Markets for medical technologies are often dominated by the U.S. and Europe, with their well developed healthcare systems, payment systems and propensity to adopt advanced technologies (arguably, to a fault).
The market for advanced medtech products providing hemostasis, wound closure, wound sealing, anti-adhesion and other functions is no less the case. The U.S. still drives the lion's share of the worldwide market, while Europe, for all its collective buying power, still runs a close second.
The 2011 and 2017 markets for products in surgical securement, encompassing sutures & staples, other mechanical closure, tapes, hemostats, fibrin & other sealants, high-strength medical adhesives, and post-surgical adhesion prevention products, are illustrated for the U.S. and Europe below, drawn from the February 2012 MedMarket Diligence Report #S190, "Worldwide Surgical Sealants, Glues, Wound Closure and Anti-Adhesion Markets, 2010-2017." The relative balance of market contribution by each is expected to change little during the forecast period, with comparable growth for both U.S. and European markets.
Source: MedMarket Diligence, LLC; Report #S190.